Filing Details
- Accession Number:
- 0001298711-23-000017
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-09-12 18:01:01
- Reporting Period:
- 2023-09-11
- Accepted Time:
- 2023-09-12 18:01:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1711279 | Krystal Biotech Inc. | KRYS | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1298711 | Suma Krishnan | C/O Krystal Biotech, Inc. 2100 Wharton Street, Suite 701 Pittsburgh PA 15203 | President, R&D | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-09-11 | 5,007 | $125.23 | 1,619,199 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-09-11 | 5,452 | $126.17 | 1,613,747 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-09-11 | 1,874 | $127.18 | 1,611,873 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-09-11 | 10,557 | $128.37 | 1,601,316 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-09-11 | 2,110 | $129.10 | 1,599,206 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-09-11 | 5,008 | $125.23 | 1,679,330 | No | 4 | S | Indirect | By Spouse |
| Common Stock | Disposition | 2023-09-11 | 5,452 | $126.17 | 1,673,878 | No | 4 | S | Indirect | By Spouse |
| Common Stock | Disposition | 2023-09-11 | 1,873 | $127.18 | 1,672,005 | No | 4 | S | Indirect | By Spouse |
| Common Stock | Disposition | 2023-09-11 | 10,557 | $128.37 | 1,661,448 | No | 4 | S | Indirect | By Spouse |
| Common Stock | Disposition | 2023-09-11 | 2,110 | $129.10 | 1,659,338 | No | 4 | S | Indirect | By Spouse |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Indirect | By Spouse |
| No | 4 | S | Indirect | By Spouse |
| No | 4 | S | Indirect | By Spouse |
| No | 4 | S | Indirect | By Spouse |
| No | 4 | S | Indirect | By Spouse |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 90,000 | Indirect | By SMK Trust |
| Common Stock | 50,000 | Indirect | By Krishnan Family Trust |
Footnotes
- The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on September 11, 2023, and will terminate on September 11, 2024, and contemplates sales of 25,000 shares per quarter with a limit price of $100.00 per share.
- The transaction was executed in multiple trades ranging from $124.7100 to $125.6950. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $125.7200 to $126.6800. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $126.7200 to $127.7100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $127.7350 to $128.7300. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $128.7400 to $129.4200. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person's spouse, Krish Krishnan. The Rule 10b5-1 trading plan adopted by the Reporting Person's spouse started on September 11, 2023, and will terminate on September 11, 2024, and contemplates sales of 25,000 shares per quarter with a limit price of $100.00 per share.
- These same shares are also being reported on a Form 4 by the Reporting Person's spouse, Krish Krishnan.
- Directly beneficially owned by Krish S. Krishnan, the spouse of the Reporting Person.
- Directly beneficially owned by the Krishnan Family Trust. The Reporting Person and her spouse are each joint beneficial owners of the trust with joint voting and investment control.
Billionaire Hedge Funds
